基本信息
views: 43
Career Trajectory
Bio
Clara Nahmias is a Research Director at CNRS and a team leader in U981 Unit in the Molecular Medicine department at the Institut Gustave Roussy (Villejuif). Her team investigates different aspects of breast and ovarian cancer progression. Seminal work of her team identified a family of proteins (ATIPs) initially isolated as interacting partners of the angiotensin AT2 receptor. Recent studies led to the discovery that ATIP3 is a new anti-cancer molecule and a promising target for personalized therapies of aggressive and metastatic breast cancer. Her team now focuses on the role of microtubule-associated proteins and the regulation of microtubule dynamics in cancer progression and resistance to chemotherapy.
Research Interests
Papers共 82 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
biorxiv(2024)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn